CSM to Celebrate Grand Opening of New Malvern Facility

Malvern, P.A.—CSM is pleased to announce that it will hold a Grand Opening and Ribbon-Cutting ceremony for its newly constructed facility at 300 Technology Drive in the Great Valley Corporate Center of Malvern, Pennsylvania on Thursday, October 15th from 1 p.m. to 7p.m. The event will feature a ribbon-cutting ceremony at 3 p.m., tours of the cGMP facility every hour, live music, complimentary gifts, food and refreshments, a partner exhibition, and grand prizes such as an Apple Watch and Lenovo Tablet. CSM, a leading provider of clinical trial supply services, has entered a long-term lease with Liberty Properties Trust and invested $1.5M to update the facility according to cGMP standards. At this new location, CSM will offer a multitude of services including packaging and labeling, temperature-controlled storage, global distribution, controlled substance handling, and high speed bottling. “Pennsylvania and Chester County are an ideal location to further our company’s growth,” said Gerald Finken, President and CEO of CSM. “The grand opening event is a celebration of everyone’s hard work, including Protecs, the Chester County Economic Development Council, our industry partners, and the employees of CSM. I see this new facility as the next step in expanding our innovative On-Demand platform to a global scale.” Present at the grand opening will be CSM’s executive staff, customers, board members, the Chester County Economic Development Council, industry partners, and elected officials. About CSM Since 1997, CSM has been providing innovative solutions to meet the complex clinical supply challenges pharmaceutical and biotechnology companies face. The company manages the clinical supply chain for hundreds of satisfied clients worldwide, offering both traditional and innovative services that keep clinical trials on time and on budget. CSM offers a full suite of cGMP-compliant services, continually delivering quality supplies to clinical sites and patients around the world. The company supports clinical trials with services such as packaging & labeling, global storage & distribution, controlled drug services, clinical supplies consulting, and returns, reconciliation & destruction. In 2001, CSM introduced the On-Demand platform, a new way of packaging and labeling clinical trial materials (CTM) for a specific subject or block subjects, upon request.

Suggested Articles

Novo Nordisk and Dicerna are teaming up on liver-related diseases, including nonalcoholic steatohepatitis (NASH), to the tune of $225 million.

After announcing it was slashing scores of jobs, Alkermes is now willing to put down nearly $1 billion to buy out CNS biotech Rodin Therapeutics.

The top-line readout appears to justify the risk the partners took when they advanced the drug despite missing the primary endpoint in phase 2.